CDEK by Data4ThePeople

Sign in Sign up

← All organizations

AVAX Technologies

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 1, 2016

Defunct as of May 17, 2015

Timeline

1990s

Jun 1, 1990
AVAX Technologies— Founded

2000s

Aug 24, 2000
Genopoietic— Acquired

2010s

May 17, 2015
AVAX Technologies— Defunct

Drugs by trial phase (8 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

m-vax

Phase 2 (7 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Genopoietic

Recent trials (10)

NCT00477906Lead sponsorPhase 3Jul 1, 2016
NCT00477906Study directorPhase 3Jul 1, 2016
NCT00660101Study directorPhase 1/Phase 2Jun 1, 2008
NCT00660101Lead sponsorPhase 1/Phase 2Jun 1, 2008
NCT00298298Study directorPhase 1/Phase 2Jan 1, 2006
NCT00298298Lead sponsorPhase 1/Phase 2Jan 1, 2006
NCT00257465Overall official - principal investigatorPhase 1/Phase 2Jun 1, 2005
NCT00257465Lead sponsorPhase 1/Phase 2Jun 1, 2005
NCT00003715Study chairPhase 2Dec 1, 1998
NCT00003715Lead sponsorPhase 2Dec 1, 1998

Details

Founded: Philadelphia, PA, US Jun 1, 1990
Last known activity: Jul 1, 2016